In8bio Inc Stock Price Prediction
| INAB Stock | USD 1.96 0.11 5.31% |
Momentum 54
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.78) | EPS Estimate Current Year (3.22) | EPS Estimate Next Year (2.46) | Wall Street Target Price 12.5 | EPS Estimate Current Quarter (1.25) |
Using In8bio hype-based prediction, you can estimate the value of In8bio Inc from the perspective of In8bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in In8bio to buy its stock at a price that has no basis in reality. In that case, they are not buying In8bio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
In8bio after-hype prediction price | USD 1.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out In8bio Basic Forecasting Models to cross-verify your projections. In8bio After-Hype Price Density Analysis
As far as predicting the price of In8bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in In8bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of In8bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
In8bio Estimiated After-Hype Price Volatility
In the context of predicting In8bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on In8bio's historical news coverage. In8bio's after-hype downside and upside margins for the prediction period are 0.10 and 9.35, respectively. We have considered In8bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
In8bio is extremely dangerous at this time. Analysis and calculation of next after-hype price of In8bio Inc is based on 3 months time horizon.
In8bio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as In8bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading In8bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with In8bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 7.39 | 0.02 | 0.16 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.96 | 1.96 | 0.00 |
|
In8bio Hype Timeline
In8bio Inc is currently traded for 1.96. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.16. In8bio is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.26%. %. The volatility of related hype on In8bio is about 1191.94%, with the expected price after the next announcement by competition of 1.80. About 25.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.45. Some equities with similar Price to Book (P/B) outperform the market in the long run. In8bio Inc recorded a loss per share of 5.26. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 6th of June 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out In8bio Basic Forecasting Models to cross-verify your projections.In8bio Related Hype Analysis
Having access to credible news sources related to In8bio's direct competition is more important than ever and may enhance your ability to predict In8bio's future price movements. Getting to know how In8bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how In8bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RNAZ | Transcode Therapeutics | 0.62 | 7 per month | 0.00 | (0.01) | 8.35 | (7.47) | 30.45 | |
| APVO | Aptevo Therapeutics | (1.44) | 6 per month | 0.00 | (0.26) | 7.81 | (9.42) | 45.42 | |
| HCWB | HCW Biologics | (0.13) | 9 per month | 0.00 | (0.22) | 13.02 | (11.97) | 41.72 | |
| LYRA | Lyra Therapeutics | (0.06) | 9 per month | 0.00 | (0.16) | 7.97 | (9.80) | 66.89 | |
| KPRX | Kiora Pharmaceuticals | 0.07 | 8 per month | 0.00 | (0.08) | 4.44 | (5.58) | 16.69 | |
| GLTO | Galecto | (2.60) | 7 per month | 7.13 | 0.12 | 17.97 | (14.66) | 273.14 | |
| APRE | Aprea Therapeutics | 0.04 | 8 per month | 0.00 | (0.27) | 4.40 | (8.40) | 17.87 | |
| ACXP | Acurx Pharmaceuticals LLC | (2.70) | 31 per month | 0.00 | (0.17) | 10.84 | (9.84) | 49.19 | |
| BCDA | Biocardia | 0.07 | 8 per month | 0.00 | (0.04) | 5.93 | (5.76) | 21.46 | |
| PHIO | Phio Pharmaceuticals Corp | (0.07) | 8 per month | 0.00 | (0.26) | 4.88 | (9.27) | 19.15 |
In8bio Additional Predictive Modules
Most predictive techniques to examine In8bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for In8bio using various technical indicators. When you analyze In8bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About In8bio Predictive Indicators
The successful prediction of In8bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as In8bio Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of In8bio based on analysis of In8bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to In8bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to In8bio's related companies. | 2025 | 2026 (projected) | Payables Turnover | 2.44 | 2.56 | Days Of Inventory On Hand | 51.33 | 45.62 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for In8bio Stock analysis
When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |